Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE S PH 7 4 IN PLASTIC CONTAINER versus PLASMA LYTE 148 IN WATER IN PLASTIC CONTAINER.
Head-to-head clinical analysis: ISOLYTE S PH 7 4 IN PLASTIC CONTAINER versus PLASMA LYTE 148 IN WATER IN PLASTIC CONTAINER.
ISOLYTE S PH 7.4 IN PLASTIC CONTAINER vs PLASMA-LYTE 148 IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Isolyte S pH 7.4 is an isotonic crystalloid solution that expands intravascular volume and replaces extracellular fluid losses. It provides electrolytes (sodium, chloride, potassium, magnesium, acetate, gluconate) to maintain acid-base balance and osmotic pressure. Acetate and gluconate are metabolized to bicarbonate, providing alkalinizing effect.
Plasma-Lyte 148 is an isotonic crystalloid solution that provides electrolyte replacement and volume expansion. It mimics plasma electrolyte composition, with acetate and gluconate as bicarbonate precursors that are metabolized to bicarbonate in the liver and kidneys, helping to maintain acid-base balance.
Intravenous infusion; dose depends on fluid and electrolyte needs, typically 500-3000 mL/24 hours for adults.
Intravenous infusion; dose determined by electrolyte and fluid requirements. Typical adult rate: 25-100 mL/hour.
None Documented
None Documented
Not applicable (components are endogenous substances; half-life reflects renal clearance and volume status, typically 2-4 hours for sodium and chloride in euvolemic patients).
Not applicable; Plasma-Lyte 148 contains electrolytes and water that distribute according to body fluid compartments; infusion rate and renal function dictate elimination; clinical context: in normal renal function, excess fluids and electrolytes are cleared with a half-life of approximately 2-4 hours.
Renal: 100% (electrolytes and buffer components are excreted unchanged by the kidneys; no biliary or fecal elimination).
Renal: >90% of infused electrolytes and water are excreted unchanged in urine. Biliary/fecal excretion is negligible (<1%).
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution